The role of viral genomics in understanding COVID-19 outbreaks in long-term care facilities.


Journal

The Lancet. Microbe
ISSN: 2666-5247
Titre abrégé: Lancet Microbe
Pays: England
ID NLM: 101769019

Informations de publication

Date de publication:
02 2022
Historique:
pubmed: 6 10 2021
medline: 6 10 2021
entrez: 5 10 2021
Statut: ppublish

Résumé

We reviewed all genomic epidemiology studies on COVID-19 in long-term care facilities (LTCFs) that had been published to date. We found that staff and residents were usually infected with identical, or near identical, SARS-CoV-2 genomes. Outbreaks usually involved one predominant cluster, and the same lineages persisted in LTCFs despite infection control measures. Outbreaks were most commonly due to single or few introductions followed by a spread rather than a series of seeding events from the community into LTCFs. The sequencing of samples taken consecutively from the same individuals at the same facilities showed the persistence of the same genome sequence, indicating that the sequencing technique was robust over time. When combined with local epidemiology, genomics allowed probable transmission sources to be better characterised. The transmission between LTCFs was detected in multiple studies. The mortality rate among residents was high in all facilities, regardless of the lineage. Bioinformatics methods were inadequate in a third of the studies reviewed, and reproducing the analyses was difficult because sequencing data were not available in many facilities.

Identifiants

pubmed: 34608459
doi: 10.1016/S2666-5247(21)00208-1
pii: S2666-5247(21)00208-1
pmc: PMC8480962
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Pagination

e151-e158

Subventions

Organisme : Wellcome Trust
ID : 207498/Z/17/Z
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R012504/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/000PR10352
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 222903/Z/21/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19027
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/CCG1860/1
Pays : United Kingdom

Informations de copyright

Crown Copyright © 2021 Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

We declare no competing interests.

Références

J Infect. 2020 Oct;81(4):621-624
pubmed: 32735893
Microb Genom. 2021 Jun;7(6):
pubmed: 34184982
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1288-1295
pubmed: 32966272
Age Ageing. 2021 Sep 11;50(5):1454-1463
pubmed: 33963830
JAMA Netw Open. 2020 Jul 1;3(7):e2015957
pubmed: 32697325
Elife. 2021 Mar 02;10:
pubmed: 33650490
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nucleic Acids Res. 2016 Jan 4;44(D1):D48-50
pubmed: 26657633
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
BMJ. 2020 Mar 26;368:m1198
pubmed: 32217618
JAMA Netw Open. 2020 Oct 1;3(10):e2024191
pubmed: 33026453
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
Nat Commun. 2022 Feb 8;13(1):751
pubmed: 35136068
J Am Geriatr Soc. 2020 Aug;68(8):1653-1656
pubmed: 32484912
J Infect. 2020 Sep;81(3):411-419
pubmed: 32504743
Science. 2020 Jul 31;369(6503):582-587
pubmed: 32513865
Wellcome Open Res. 2020 Oct 7;5:232
pubmed: 33564722
EClinicalMedicine. 2020 Nov;28:100597
pubmed: 33173854
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
EClinicalMedicine. 2020 Sep;26:100533
pubmed: 32923993
Lancet Healthy Longev. 2020 Oct;1(1):e21-e31
pubmed: 34173614
Clin Infect Dis. 2021 Jun 1;72(11):e727-e735
pubmed: 32954414
Nat Microbiol. 2020 Jul;5(7):876-877
pubmed: 32427978
Lancet Infect Dis. 2020 Nov;20(11):1263-1272
pubmed: 32679081
J Hosp Infect. 2021 Apr;110:178-183
pubmed: 33571558
J Hosp Infect. 2020 Jun;105(2):111-112
pubmed: 32277963
Science. 2021 Feb 5;371(6529):
pubmed: 33303686

Auteurs

Dinesh Aggarwal (D)

Department of Medicine, University of Cambridge, Cambridge, UK.
Public Health England, London, UK.
Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.
Wellcome Sanger Institute, Hinxton, Cambridge, UK.

Richard Myers (R)

Public Health England, London, UK.

William L Hamilton (WL)

Department of Medicine, University of Cambridge, Cambridge, UK.
Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.

Tehmina Bharucha (T)

Public Health England, London, UK.
Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, UK.
Lao-Oxford-Mahosot Hospital, Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos.

Niamh M Tumelty (NM)

Cambridge University Libraries, University of Cambridge, Cambridge, UK.

Colin S Brown (CS)

Public Health England, London, UK.
Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, UK.
Lao-Oxford-Mahosot Hospital, Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos.

Emma J Meader (EJ)

Norfolk and Norwich University Hospital, Norwich, UK.

Tom Connor (T)

Organisms and Environment Division, School of Biosciences, Cardiff University, Cardiff, Wales, UK.
Public Health Wales, University Hospital of Wales, Cardiff, UK.
Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Darren L Smith (DL)

Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.

Declan T Bradley (DT)

Public Health Agency, Belfast, UK.
Centre for Public Health, Queen's University Belfast, Belfast, UK.

Samuel Robson (S)

University of Portsmouth, Centre for Enzyme Innovation, Portsmouth, UK.

Matthew Bashton (M)

Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.

Laura Shallcross (L)

Institute of Health Informatics, University College London, London, UK.

Maria Zambon (M)

Public Health England, London, UK.

Ian Goodfellow (I)

Department of Pathology, University of Cambridge, Cambridge, UK.

Meera Chand (M)

Public Health England, London, UK.
Guy's and St Thomas' NHS Foundation Trust, London, UK.

Justin O'Grady (J)

Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

M Estée Török (ME)

Department of Medicine, University of Cambridge, Cambridge, UK.
Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.

Sharon J Peacock (SJ)

Department of Medicine, University of Cambridge, Cambridge, UK.
Wellcome Sanger Institute, Hinxton, Cambridge, UK.

Andrew J Page (AJ)

Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH